Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solange Peters

Showing results (131-140 of 362) with videos related to

Pageof 37
Sort By:
BMJ Open|July 11, 2019
Implementation of the Symptom Navi © Programme for cancer patients in the Swiss outpatient setting: a study protocol for a cluster randomised pilot study (Symptom Navi© Pilot Study)Marika Bana, Karin Ribi, Susanne Kropf-Staub, et al.
Ebiomedicine|March 20, 2026
Multidisciplinary international expert consensus recommendations on tissue acquisition in non-small cell lung cancerPyng Lee, Karim Abdelhamid, Rachel Butler, et al.
Revue Medicale Suisse|November 4, 2020
[Lung cancer screening: what can we tell our patients while we await a screening program ?]Kevin Selby, Rosanne Gubelmann, Alban Lovis, et al.
European Journal of Cancer Care|September 21, 2022
Patients' experiences with cancer care in Switzerland: Results of a multicentre cross-sectional surveyChantal Arditi, Manuela Eicher, Sara Colomer-Lahiguera, et al.
Journal for Immunotherapy of Cancer|March 19, 2021
Fast progression in non-small cell lung cancer: results from the randomized phase III OAK study evaluating second-line atezolizumab versus docetaxelDavid Gandara, Martin Reck, Denis Moro-Sibilot, et al.
Cancers|May 11, 2024
Long-Term Results of Stereotactic Radiotherapy in Patients with at Least 10 Brain Metastases at DiagnosisRémy Kinj, Andreas Felix Hottinger, Till Tobias Böhlen, et al.
Journal of the National Cancer Institute|April 10, 2008
A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trialSerge Leyvraz, Sandro Pampallona, Giovanni Martinelli, et al.
The Annals of Thoracic Surgery|March 22, 2008
Distribution of free and liposomal doxorubicin after isolated lung perfusion in a sarcoma modelHua Yan, Cai Cheng, Amina Haouala, et al.
ESMO Open|June 26, 2020
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancerAntonio Passaro, Alfredo Addeo, Christophe Von Garnier, et al.
Translational Lung Cancer Research|January 9, 2026
A systematic literature review and meta-analysis on the efficacy and safety of PD-(L)1 inhibitors for the first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer in Asian and non-Asian patientsNicolas Girard, Daniel Tan, Diego Cortinovis, et al.
Pageof 37

Showing results (131-140 of 362) with videos related to

Sort By:
Pageof 37
BMJ Open|July 11, 2019
Implementation of the Symptom Navi © Programme for cancer patients in the Swiss outpatient setting: a study protocol for a cluster randomised pilot study (Symptom Navi© Pilot Study)Marika Bana, Karin Ribi, Susanne Kropf-Staub, et al.
Ebiomedicine|March 20, 2026
Multidisciplinary international expert consensus recommendations on tissue acquisition in non-small cell lung cancerPyng Lee, Karim Abdelhamid, Rachel Butler, et al.
Revue Medicale Suisse|November 4, 2020
[Lung cancer screening: what can we tell our patients while we await a screening program ?]Kevin Selby, Rosanne Gubelmann, Alban Lovis, et al.
European Journal of Cancer Care|September 21, 2022
Patients' experiences with cancer care in Switzerland: Results of a multicentre cross-sectional surveyChantal Arditi, Manuela Eicher, Sara Colomer-Lahiguera, et al.
Journal for Immunotherapy of Cancer|March 19, 2021
Fast progression in non-small cell lung cancer: results from the randomized phase III OAK study evaluating second-line atezolizumab versus docetaxelDavid Gandara, Martin Reck, Denis Moro-Sibilot, et al.
Cancers|May 11, 2024
Long-Term Results of Stereotactic Radiotherapy in Patients with at Least 10 Brain Metastases at DiagnosisRémy Kinj, Andreas Felix Hottinger, Till Tobias Böhlen, et al.
Journal of the National Cancer Institute|April 10, 2008
A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trialSerge Leyvraz, Sandro Pampallona, Giovanni Martinelli, et al.
The Annals of Thoracic Surgery|March 22, 2008
Distribution of free and liposomal doxorubicin after isolated lung perfusion in a sarcoma modelHua Yan, Cai Cheng, Amina Haouala, et al.
ESMO Open|June 26, 2020
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancerAntonio Passaro, Alfredo Addeo, Christophe Von Garnier, et al.
Translational Lung Cancer Research|January 9, 2026
A systematic literature review and meta-analysis on the efficacy and safety of PD-(L)1 inhibitors for the first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer in Asian and non-Asian patientsNicolas Girard, Daniel Tan, Diego Cortinovis, et al.
Pageof 37